Real-time Stock quotes, portfolio, LIVE TV and more.
|
Oct 10, 2009, 04.01 PM IST
Motilal Oswal has come out with its earning estimates for Pharmaceutical sector for the quarter ended September 2009. According to the research firm, Ranbaxy Labs' September quarter net sales are expected to go up by 0.8% to Rs 1,867.3 crore on YoY basis.
Motilal Oswal has come out with its earning estimates for Pharmaceutical sector for the quarter ended September 2009. According to the research firm, Ranbaxy Labs ' September quarter net sales are expected to go up by 0.8% to Rs 1,867.3 crore on YoY basis.
The company's profit after tax is expected to go up by 24% to Rs 19.3 crore on YoY basis.
Set email alert for Tags: Motilal Oswal, Ranbaxy Labs
|
News Videos
|